Literature DB >> 15167188

Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.

Ingebjørg Buajordet1, Anne-Cathrine Naess, Dag Jacobsen, Odd Brørs.   

Abstract

OBJECTIVE: An increasing and serious heroin overdose problem in Oslo has mandated the increasing out-of-hospital use of naloxone administered by paramedics. The aim of this study was to determine the frequencies and characteristics of adverse events related to this out-of-hospital administration by paramedics.
METHODS: A one-year prospective observational study from February 1998 to January 1999 was performed in patients suspected to be acutely overdosed by an opioid. A total of 1192 episodes treated with naloxone administered by the Emergency Medical Service system in Oslo, were included. The main outcome variable was adverse events observed immediately after the administration of naloxone.
RESULTS: The mean age of patients included was 32.6 years, and 77% were men. Adverse events suspected to be related to naloxone treatment were reported in 45% of episodes. The most common adverse events were related to opioid withdrawal (33%) such as gastrointestinal disorders, aggressiveness, tachycardia, shivering, sweating and tremor. Cases of confusion/restlessness (32%) might be related either to opioid withdrawal or to the effect of the heroin in combination with other drugs. Headache and seizures (25%) were probably related to hypoxia. Most events were non-serious. In three episodes (0.3%) the patients were hospitalized because of adverse events.
CONCLUSION: Although adverse events were common among patients treated for opioid overdose in an out-of-hospital setting, serious complications were rare. Out-of-hospital naloxone treatment by paramedics seems to save several lives a year without a high risk of serious complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15167188     DOI: 10.1097/00063110-200402000-00004

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  43 in total

Review 1.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

2.  Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city.

Authors:  Susan G Sherman; Yingkai Cheng; Alexander H Kral
Journal:  Drug Alcohol Depend       Date:  2006-11-15       Impact factor: 4.492

3.  A response to the opioid overdose epidemic: naloxone nasal spray.

Authors:  Daniel P Wermeling
Journal:  Drug Deliv Transl Res       Date:  2013-02-01       Impact factor: 4.617

4.  Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities.

Authors:  Mark Faul; Michael W Dailey; David E Sugerman; Scott M Sasser; Benjamin Levy; Len J Paulozzi
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

Review 5.  Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.

Authors:  Daniel P Wermeling
Journal:  Ther Adv Drug Saf       Date:  2015-02

6.  The Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical Specialty.

Authors:  Nicholas J Connors; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2016-06-07

7.  Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings.

Authors:  Abby M Bailey; Daniel P Wermeling
Journal:  Ann Pharmacother       Date:  2014-02-12       Impact factor: 3.154

8.  Reversal of Opioid-Induced Ventilatory Depression Using Low-Dose Naloxone (0.04 mg): a Case Series.

Authors:  Hong K Kim; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2016-03

9.  Pre-hospital treatment of acute poisonings in Oslo.

Authors:  Fridtjof Heyerdahl; Knut E Hovda; Mari A Bjornaas; Anne K Nore; Jose C P Figueiredo; Oivind Ekeberg; Dag Jacobsen
Journal:  BMC Emerg Med       Date:  2008-11-24

10.  Can we prevent drug related deaths by training opioid users to recognise and manage overdoses?

Authors:  Romina Lopez Gaston; David Best; Victoria Manning; Ed Day
Journal:  Harm Reduct J       Date:  2009-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.